These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

228 related items for PubMed ID: 4246192

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Origin of urinary fibrin/fibrinogen degradation products in glomerulonephritis.
    Ekberg M, Pandolfi M.
    Br Med J; 1975 Apr 05; 2(5961):17-9. PubMed ID: 48398
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Comparison of the relative fibrinogenolytic, fibrinolytic and thrombolytic properties of tissue plasminogen activator and urokinase in vitro.
    Matsuo O, Rijken DC, Collen D.
    Thromb Haemost; 1981 Jun 30; 45(3):225-9. PubMed ID: 7025339
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. The kidney and fibrinolysis in man.
    Gibinski K, Nowak A.
    Experientia; 1968 Aug 15; 24(8):787-8. PubMed ID: 5683165
    [No Abstract] [Full Text] [Related]

  • 9. Serum and urinary fibrin-fibrinogen degradation products in glomerulonephritis.
    Clarkson AR, MacDonald MK, Petrie JJ, Cash JD, Robson JS.
    Br Med J; 1971 Aug 15; 3(5772):447-51. PubMed ID: 5567767
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [Effect of the enzyme preparation longolytin on fibrinolysis in animals].
    Serebriakova TN, Andreenko GV, Tsymanovich SG, Maksimova RA, Sharkova TS.
    Nauchnye Doki Vyss Shkoly Biol Nauki; 1985 Aug 15; (2):66-71. PubMed ID: 3157406
    [Abstract] [Full Text] [Related]

  • 12. Resting levels of blood fibrinolysis in hyperlipoproteinemia.
    Brakman P, Astrup T, Levy RI, Fredrickson DS.
    J Appl Physiol; 1974 Apr 15; 36(4):430-3. PubMed ID: 4274385
    [No Abstract] [Full Text] [Related]

  • 13. Fibrinolysis in health and disease: severe abnormalities in systemic lupus erythematosus.
    Glas-Greenwalt P, Kant KS, Allen C, Pollak VE.
    J Lab Clin Med; 1984 Dec 15; 104(6):962-76. PubMed ID: 6239000
    [Abstract] [Full Text] [Related]

  • 14. Urinary procoagulant and fibrinolytic activity in human glomerulonephritis. Relationship with renal function.
    Colucci M, Semeraro N, Montemurro P, Chiumarulo P, Triggiani R, Morrone LF, Schena FP.
    Kidney Int; 1991 Jun 15; 39(6):1213-7. PubMed ID: 1910125
    [Abstract] [Full Text] [Related]

  • 15. [Fibrinolytic activity of the urine during chronic glomerulonephritis and amyloidosis].
    Podorol'skaia LV, Andreenko GV, Poliantseva LR, Bumblite ID.
    Vopr Med Khim; 1999 Jun 15; 45(2):158-64. PubMed ID: 10378306
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Relationship between gender difference in intravascular aggregation of platelets and the fibrinolytic pathway in the rat.
    Oyekan AO, Botting JH.
    Arch Int Pharmacodyn Ther; 1991 Jun 15; 313():176-92. PubMed ID: 1816761
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.